Plasvacc
24/7 HELP HOTLINE WITHIN AUSTRALIA 1800 752 762
  • Home
  • Products
    • Products overview
    • Equiplas
    • Equiplas-R
    • Equiplas-E
    • Caniplas
    • Caniplas E
    • CaniPRBC
    • Camelplas
    • Diagnostic Kits
  • How to buy
  • Technology
    • Plasma Therapy
    • Collection process
    • Thawing instructions
    • Product usage
    • Storage
  • Research
    • Scientific papers
    • White papers
    • Background papers
  • About
    • Company overview
    • Animal ethics
    • Plasvacc team
    • Regional commitment
  • Blog
  • Contact

Blog

Home» Blog

Introducing Anubis Retirement

Posted on February 23, 2023 by Tamara Maudsley in Canine

At Plasvacc we’re extremely proud—and honoured—to be in a position to give our donor dogs (ex-racing greyhounds given a second chance at life) full opportunity to live their best life. With a strict commitment to animal welfare, it has always been our mission to ensure our donor animals want for nothing while receiving the best […]

View Post

What is Plasma Therapy?

Posted on December 16, 2022 by Tamara Maudsley in Product Science

Hypermmunised plasma, such as that which comprises our entire range of plasma treatments from Equiplas, to Caniplas to Camelplas, has become an indispensable tool to veterinary practices all over the world. But what is plasma therapy and how did it come to be? In a veterinary context, at its simplest, plasma therapy involves administering plasma […]

View Post

Queensland Dignitaries Visit Plasvacc In Recognition Of Contribution To Regional Export Market

Posted on November 30, 2022 by Tamara Maudsley in Plasvacc News

KALBAR, QUEENSLAND — Plasvacc Pty Ltd hosted a delegation of Queensland dignitaries at its Kalbar headquarters on Tuesday, November 22. Led by Queensland Assistant Minister of Treasury, Charis Mullen, she was joined by Trade & Investment Queensland’s Southern Regional Network leadership team of Manager, Reg Roberts and Principle Trade and Investment Officer, Julie Mark. The […]

View Post

Plasvacc Named ‘Best Small Business’ at 2022 Premier of Queensland Export Awards

Posted on October 19, 2022 by Tamara Maudsley in Plasvacc News

KALBAR, QUEENSLAND — Plasvacc Pty Ltd is proud to have been selected as “Best Small Business” at the 2022 Premier of Queensland Export Awards, held to recognise the state’s top contributors to its robust export industry. Hosted by Premier Annastacia Palaszczuk and Treasurer and Minister for Trade and Investment, Cameron Dick, a total of 34 […]

View Post

Evaluating the Benefits of Equiplas: An Interview with Dr Jaco Joubert, BVSc

Posted on October 11, 2022 by Tamara Maudsley in Equine

With its efficacy in treating so many different indications, it can be hard to overstate the role Equiplas plays in equine practices across Australia. We sat down with Dr. Jaco Joubert to learn about how he incorporates Equiplas into his practice as well as his thoughts on the role equine plasma has played in the […]

View Post

Equine Diagnostic Kits: A Closer Look

Posted on September 1, 2022 by Tamara Maudsley in Equine

While we’ve built our name and reputation on over three decades of providing the safest, most effective equine plasma we can, we’re also proud to serve as a trusted source for safe, timely and effective veterinary diagnostic solutions essential for both acute and preventative care for your equine patients. As they say, an ounce of […]

View Post

Plasvacc Expands to UK, Acquiring Veterinary Immunogenics

Posted on July 27, 2022 by Tamara Maudsley in Plasvacc News

PENRITH, UNITED KINGDOM — Plasvacc UK Ltd. is pleased to announce its entry into the United Kingdom through its acquisition of Veterinary Immunogenics Inc. Effective immediately, Plasvacc will undertake the day-to-day management of Veterinary Immunogenics under the oversight of site manager Fergus Macarthur. Incorporated in 1992, Veterinary Immunogenics has been producing and supplying hyperimmunised equine […]

View Post

Why Caniplas Should Be in Every Vets’ Freezer

Posted on July 7, 2022 by Tamara Maudsley in Canine

The process of plasmapheresis has been a staple of modern medicine for nearly 60 years, enabling countless therapies across a wide variety of care disciplines. And while its introduction into veterinary standards of care took several more decades, the process was originally successfully proven all the way back in 1916 with a canine patient. Today, […]

View Post

Ensuring Optimal Outcomes For Foals Faced With Rhodococcus Equi

Posted on June 8, 2022 by Tamara Maudsley in Equine

What is Rhodococcus equi? A bacterium found in soil worldwide, Rhodococcus equi (R. equi) is a common cause of bronchopneumonia in foals between 3 weeks and 5 months of age. While the survival rate of R equi pneumonia is upwards of 70% with appropriate therapy, the case fatality rate without therapy is a staggering 80%. […]

View Post

How Our Plasma Purity and Safety Protocols Impact Your Patient Outcomes

Posted on May 27, 2022 by Tamara Maudsley in Product Science

While the efficacy of plasma treatments has been long proven, they’re still only as effective as they are safe. With the highest possible level of safety and efficacy serving as our primary goal for each and every one of our products here at Plasvacc, we take great pride in adhering to the most stringent quality […]

View Post
  • 1
  • 2
FoalsBestStart.com
Want the best for your dog?
See more products

About us

Plasvacc manufactures and distributes high quality hyperimmunised blood plasma products used to supplement the immune response system in animals. Plasma therapy shortens the course of treatments, reduces hospitalisation periods and lessens the quantity of drugs required to treat a variety of medical conditions.

SIGN UP FOR OUR MAILING LIST





    Contact us

    • Telephone: +61 7 5463 7600
    • Technical Support: 1-800-PLASMA | 1-800-752762
    • plasmail@plasvacc.com
    • Contact Us
      • ✉
      • 
      • 
      • 
    • Products
      • Equiplas
      • Equiplas-R
      • Equiplas-E
      • Caniplas
      • Caniplas E
      • CaniPRBC
      • Camelplas
      • Diagnostic Kits
    • How to buy
      • Wholesalers
    • Company overview
      • Plasvacc team
      • Animal ethics
      • Regional commitment
    • Research
      • Scientific papers
      • Background papers
      • White papers
    • Technology
      • Plasma therapy
      • Collection process
      • Thawing Instructions
      • Product usage
      • Storage

    (c) 2012 Plasvacc | All Rights Reserved | privacy policy

    Manage Cookie Consent
    We use cookies to optimise our website and our service.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    Manage options Manage services Manage vendors Read more about these purposes
    Preferences
    {title} {title} {title}